1. Home
  2. JJSF vs CERT Comparison

JJSF vs CERT Comparison

Compare JJSF & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JJSF
  • CERT
  • Stock Information
  • Founded
  • JJSF 1971
  • CERT 2008
  • Country
  • JJSF United States
  • CERT United States
  • Employees
  • JJSF N/A
  • CERT N/A
  • Industry
  • JJSF Specialty Foods
  • CERT Retail: Computer Software & Peripheral Equipment
  • Sector
  • JJSF Consumer Staples
  • CERT Technology
  • Exchange
  • JJSF Nasdaq
  • CERT Nasdaq
  • Market Cap
  • JJSF N/A
  • CERT 2.3B
  • IPO Year
  • JJSF N/A
  • CERT 2020
  • Fundamental
  • Price
  • JJSF $115.74
  • CERT $11.87
  • Analyst Decision
  • JJSF Buy
  • CERT Buy
  • Analyst Count
  • JJSF 2
  • CERT 6
  • Target Price
  • JJSF $142.50
  • CERT $15.60
  • AVG Volume (30 Days)
  • JJSF 144.2K
  • CERT 2.9M
  • Earning Date
  • JJSF 05-06-2025
  • CERT 05-05-2025
  • Dividend Yield
  • JJSF 2.69%
  • CERT N/A
  • EPS Growth
  • JJSF N/A
  • CERT N/A
  • EPS
  • JJSF 3.89
  • CERT N/A
  • Revenue
  • JJSF $1,585,410,000.00
  • CERT $394,498,000.00
  • Revenue This Year
  • JJSF $5.67
  • CERT $11.41
  • Revenue Next Year
  • JJSF $3.43
  • CERT $8.78
  • P/E Ratio
  • JJSF $29.85
  • CERT N/A
  • Revenue Growth
  • JJSF 0.49
  • CERT 9.37
  • 52 Week Low
  • JJSF $112.27
  • CERT $8.64
  • 52 Week High
  • JJSF $180.80
  • CERT $17.94
  • Technical
  • Relative Strength Index (RSI)
  • JJSF 33.60
  • CERT 44.02
  • Support Level
  • JJSF $112.40
  • CERT $11.22
  • Resistance Level
  • JJSF $132.14
  • CERT $13.18
  • Average True Range (ATR)
  • JJSF 4.94
  • CERT 0.72
  • MACD
  • JJSF -1.92
  • CERT -0.34
  • Stochastic Oscillator
  • JJSF 11.03
  • CERT 15.73

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: